Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Luttenberger, Katharina ^a   Hofner, Benjamin ^a   Graessel, Elmar ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Dementia; Follow up study; Non drug therapy; Nursing home; RCT

Indexed keywords

AGED; ALZHEIMER'S DISEASE ASSESSMENT SCALE; ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; ERLANGEN TEST OF ACTIVITIES OF DAILY LIVING; FEMALE; FOLLOW UP; GERMANY; GROUP THERAPY; HOME CARE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MOTOR STIMULATION,ADL AND COGNITION, SPIRITUAL THERAPY; NURSING CARE; NURSING HOME; PRIMARY DEGENERATIVE DEMENTIA; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ACTIVITIES OF DAILY LIVING; AGED; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; PREVALENCE; RISK FACTORS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84870333656     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-151     Document Type: Article

References (28)

1. Olazarán J, Reisberg B, Clare L, Cruz I, Peña-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, Spector A, Fazio S, Bond J, Kivipelto M, Brodaty H, Rojo JM, Collins H, Teri L, Mittelman M, Orrell M, Feldmann HH, Muñiz R. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 2010, 30(2):161-178. 10.1159/000316119, 20838046.
2. NICE [National Institute for Health and Clinical Excellence] 2007, 1-56. London: National Institute for Health and Clinical Excellence, Social Care Institute for Excellence: NICE clinical guideline, Dementia: Supporting people with dementia and their carers in health and social care, NICE [National Institute for Health and Clinical Excellence].
3. Ballard C, Khan Z, Clack H, Corbett A. Nonpharmacological treatment of Alzheimer disease. Can J Psychiatr 2011, 56(10):589-595.
4. Gräßel E, Wiltfang J, Kornhuber J. Non-drug therapies for dementia: an overview of the current situation with regard to proof of effectiveness. Dement Geriatr Cogn Disord 2003, 15(3):115-125. 10.1159/000068477, 12584426.
5. Graessel E, Stemmer R, Eichenseer B, Pickel S, Donath C, Kornhuber J, Luttenberger K. Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomised, controlled trial. BMC Med 2011, 9(1):129. 10.1186/1741-7015-9-129, 3254071, 22133165.
6. Chapman SB, Weiner MF, Rackley A, Hynan LS, Zientz J. Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil. J Speech Lang Hear Res 2004, 47(5):1149-1163. 10.1044/1092-4388(2004/085), 15603468.
7. Requena C, Maestu F, Campo P, Fernandez A, Ortiz T. Effects of cholinergic drugs and cognitive training on dementia: 2-year follow-up. Dement Geriatr Cogn Disord 2006, 22(4):339-345. 10.1159/000095600, 16954689.
8. Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 2001, 58(3):427-433. 10.1001/archneur.58.3.427, 11255446.
9. Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease. CNS Drugs 2006, 20(4):311-325. 10.2165/00023210-200620040-00005, 16599649.
10. Clare L, Wilson BA, Carter G, Roth I, Hodges JR. Relearning face-name associations in early Alzheimer's disease. Neuropsychology 2002, 15:538-547.
11. Zanetti O, Zanieri G, Di Giovanni G, De Vreese LP, Pezzini A, Metitieri T, Trabucchi M. Effectiveness of procedural memory stimulation in mild Alzheimer's disease patients: A controlled study. Neuropsychol Rehabil 2001, 11(3/4):263-272.
12. Woods B, Aguirre EP, Spector A, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012, (2). CD005562.
13. Waldemar G, Waldorff FB, Buss DV, Eckermann A, Keiding N, RishØj S, Siersma V, SØrensen LV, Vogel A. The Danish Alzheimer Intervention Study: Rationale, Study Design and Baseline Characteristics of the cohort. Neuroepidemiology 2011, 36(1):52-61. 10.1159/000322942, 21196773.
14. Eichenseer B, Graessel E. Aktivierungstherapie für Menschen mit Demenz - motorisch - alltagspraktisch - kognitiv - spirituell [MAKS: Activation therapy for persons with dementia] 2011, München: Elsevier.
15. Luttenberger K, Donath C, Uter W, Graessel E. Effects of multimodal non-drug MAKS therapy on Dementia symtoms and need for care in patients with degernative Dementia in the nursing home. J Am Geriatr Soc 2012, 60(5):830-840. 10.1111/j.1532-5415.2012.03938.x, 22468985.
16. Folstein M, Folstein S, McHugh P. " Mini-Mental State" : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198. 10.1016/0022-3956(75)90026-6, 1202204.
17. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984, 141(11):1356-1364.
18. Graessel E, Viegas R, Stemmer R, Küchly B, Kornhuber J, Donath C. The Erlangen Test of Activities of Daily Living: first results on reliability and validity of a short performance test to measure fundamental activities of daily living in dementia patients. Int Psychogeriatr 2009, 21(1):103-112. 10.1017/S1041610208007710, 18925975.
19. Spiegel R, Brunner C, Ermini-Fünfschilling D, Monsch A, Notter M, Puxty J, Tremmel L. A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients). Am J Geriatr Psychiatry 1991, 39(4):339-347.
20. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40(5):373-383. 10.1016/0021-9681(87)90171-8, 3558716.
21. Hedges LV, Olkin I. Statistical methods for meta-analysis 1985, New York: Academic Press.
22. R Development Core Team R: A language and environment for statistical computing 2011, Vienna: R Foundation for Statistical Computing, 2141st, http://www.R-project.org, R Development Core Team.
23. IBM SPSS statistics 2011, New York: IBM corporation, 19, http://www-01.ibm.com/software/de/analytics/spss/, IBM.
24. Giordano M, Dominguez LJ, Vitrano T, Curatolo M, Ferlisi A, Di Prima A, Belvedere M, Barbagallo M. Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD). Arch Gerontol Geriatr 2010, 51(3):245-249. 10.1016/j.archger.2009.11.008, 19969381.
25. Ito K, Ahadieh S, Corrigan B, French J, Fullerton T, Tensfeldt T. Disease progression meta-analysis model in Alzheimer's disease. Alzheimers Dement 2010, 6(1):39-53. 10.1016/j.jalz.2009.05.665, 19592311.
26. Guetin S, Portet F, Picot MC, Pommie C, Messaoudi M, Djabelkir L, Olsen AL, Cano MM, Lecourt E, Touchon J. Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study. Dement Geriatr Cogn Disord 2009, 28(1):36-46. 10.1159/000229024, 19628939.
27. Graff MJ, Vernooij-Dassen M, Thijssen M, Dekker J, Hoefnagels WH, Olde Rikkert MG. Effects of community occupational therapy on quality of life, mood, and health status in dementia patients and their caregivers: a randomized controlled trail. J Gerontol A Biol Sci Med Sci 2007, 62(9):1002-1009. 10.1093/gerona/62.9.1002, 17895439.
28. McGill R, Tukey JW, Larsen WA. Variations of box plots. Am Stat 1978, 32:12-16.